C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 495/04 (2006.01) A61K 31/505 (2006.01) A61K 31/519 (2006.01) C07D 471/04 (2006.01) C07D 475/02 (2006.01) C07D 487/04 (2006.01) C07D 491/048 (2006.01) C07D 498/04 (2006.01) C07D 513/04 (2006.01)
Patent
CA 2205274
The present invention relates to novel compounds of the formula I (see formula I) (preferred values are as follows: fused heterocyclic ring A is (see formula II) or (see formula III) is phenyl substituted at the 2 position with fluoro, bromo, chloro, methyl or trifluoro- methyl, R2 is phenyl substituted at the 2 position with fluoro, chloro, hydroxy or cyano, and the dashed line is a double bond), and their pharmaceutically acceptable salts, and pharmaceutical compositions and methods of treating neurode- generative and CNS-trauma related conditions.
Chenard Bertrand Leo
Elliott Mark Leonard
Welch Willard Mckowan Jr.
Pfizer Inc.
Smart & Biggar
LandOfFree
Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1508483